Neovasc Inc. Income from Continuous Operations

Income from Continuous Operations of NVCN for past 10 years: annual, quarterly and twelve month trailing (TTM) including Income from Continuous Operations growth rates and interactive chart.


Highlights and Quick Summary

  • Income from Continuous Operations for the quarter ending March 31, 2022 was $-10.2 Million (a 65.11% increase compared to previous quarter)
  • Year-over-year quarterly Income from Continuous Operations increased by 12.47%
  • Annual Income from Continuous Operations for 2021 was $-24.9 Million (a -13.26% decrease from previous year)
  • Annual Income from Continuous Operations for 2020 was $-28.7 Million (a -18.32% decrease from previous year)
  • Annual Income from Continuous Operations for 2019 was $-35.1 Million (a -67.47% decrease from previous year)
  • Twelve month Income from Continuous Operations ending March 31, 2022 was $-32.9 Million (a 32.11% increase compared to previous quarter)
  • Twelve month trailing Income from Continuous Operations increased by 27.16% year-over-year
Trailing Income from Continuous Operations for the last four month:
31 Mar '22 31 Dec '21 30 Sep '21 30 Jun '21
$-32.9 Million $-24.9 Million $-23.2 Million $-25.9 Million
Visit stockrow.com/NVCN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Income from Continuous Operations of Neovasc Inc.

Most recent Income from Continuous Operationsof NVCN including historical data for past 10 years.

Interactive Chart of Income from Continuous Operations of Neovasc Inc.

Neovasc Inc. Income from Continuous Operations for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $-10.16
2021 $-6.15 $-7.54 $-9.03 $-2.17 $-24.89
2020 $-4.42 $-10.23 $-9.93 $-4.11 $-28.7
2019 $-12.35 $-6.2 $-7.96 $-8.62 $-35.13
2018 $11.68 $-14.64 $-49.15 $-55.88 $-107.98
2017 $-5.03 $-4.7 $-5.34 $-7.85 $-22.91
2016 $37.21 $-29.14 $-83.69 $-10.88 $-86.49
2015 $-7.38 $-7.65 $-6.75 $-4.96 $-26.73
2014 $-6.06 $-4.05 $-5.92 $-0.35 $-17.18
2013 $-2.15 $-1.39 $-1.21 $-1.85 $-6.56
2012 $3.64 $-1.21 $-1.5 $-1.26 $-4.95
2011 $-0.99 $-3.91

Business Profile of Neovasc Inc.

Sector: Healthcare
Industry: Medical Devices
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.